LIGHT

LIGHT (HVEM-L, TNFSF14, or CD258), an entity homologous to lymphotoxins, with inducible nature and the ability to compete with herpes simplex virus glycoprotein D for herpes virus entry mediator (HVEM)/tumor necrosis factor (TNF)-related 2, is a member of the TNF superfamily. It is expressed as a ho...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 11; p. e0166589
Main Authors Jo, Jae-Cheol, Kim, Jeong Yi, Heo, Sook-Kyoung, Noh, Eui-Kyu, Choi, Yunsuk, Gwon, Gi-Dong, Min, Young Joo, Baek, Jin Ho, Koh, SuJin, Kim, Hawk
Format Journal Article
LanguageEnglish
Published Public Library of Science 11.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract LIGHT (HVEM-L, TNFSF14, or CD258), an entity homologous to lymphotoxins, with inducible nature and the ability to compete with herpes simplex virus glycoprotein D for herpes virus entry mediator (HVEM)/tumor necrosis factor (TNF)-related 2, is a member of the TNF superfamily. It is expressed as a homotrimer on activated T cells and dendritic cells (DCs), and has three receptors: HVEM, LT-[beta] receptor (LT[beta]R), and decoy receptor 3 (DcR3). So far, three receptors with distinct cellular expression patterns are known to interact with LIGHT. Follicular DCs and stromal cells bind LIGHT through LT[beta]R. We monitored the effects of LIGHT on human bone marrow-derived mesenchymal stem cells (BM-MSCs). At first, we checked the negative and positive differentiation markers of BM-MSCs. And we confirmed the quality of MSCs by staining cells undergoing adipogenesis (Oil Red O staining), chondrogenesis (Alcian blue staining), and osteogenesis (Alizarin red staining). After rhLIGHT treatment, we monitored the count, viability, and proliferation of cells and cell cycle distribution. PDGF and TGF[beta] production by rhLIGHT was examined by ELISA, and the underlying biological mechanisms were studied by immunoblotting by rhLIGHT treatment. LT[beta]R was constitutively expressed on the surface of human BM-MSCs. Cell number and viability increased after rhLIGHT treatment. BM-MSC proliferation was induced by an increase in the S/G.sub.2 /M phase. The expression of not only diverse cyclins such as cyclin B1, D1, D3, and E, but also CDK1 and CDK2, increased, while that of p27 decreased, after rhLIGHT treatment. RhLIGHT-induced PDGF and TGF[beta] production mediated by STAT3 and Smad3 activation accelerated BM-MSC proliferation. Thus, LIGHT and LT[beta]R interaction increases the survival and proliferation of human BM-MSCs, and therefore, LIGHT might play an important role in stem cell therapy.
AbstractList LIGHT (HVEM-L, TNFSF14, or CD258), an entity homologous to lymphotoxins, with inducible nature and the ability to compete with herpes simplex virus glycoprotein D for herpes virus entry mediator (HVEM)/tumor necrosis factor (TNF)-related 2, is a member of the TNF superfamily. It is expressed as a homotrimer on activated T cells and dendritic cells (DCs), and has three receptors: HVEM, LT-[beta] receptor (LT[beta]R), and decoy receptor 3 (DcR3). So far, three receptors with distinct cellular expression patterns are known to interact with LIGHT. Follicular DCs and stromal cells bind LIGHT through LT[beta]R. We monitored the effects of LIGHT on human bone marrow-derived mesenchymal stem cells (BM-MSCs). At first, we checked the negative and positive differentiation markers of BM-MSCs. And we confirmed the quality of MSCs by staining cells undergoing adipogenesis (Oil Red O staining), chondrogenesis (Alcian blue staining), and osteogenesis (Alizarin red staining). After rhLIGHT treatment, we monitored the count, viability, and proliferation of cells and cell cycle distribution. PDGF and TGF[beta] production by rhLIGHT was examined by ELISA, and the underlying biological mechanisms were studied by immunoblotting by rhLIGHT treatment. LT[beta]R was constitutively expressed on the surface of human BM-MSCs. Cell number and viability increased after rhLIGHT treatment. BM-MSC proliferation was induced by an increase in the S/G.sub.2 /M phase. The expression of not only diverse cyclins such as cyclin B1, D1, D3, and E, but also CDK1 and CDK2, increased, while that of p27 decreased, after rhLIGHT treatment. RhLIGHT-induced PDGF and TGF[beta] production mediated by STAT3 and Smad3 activation accelerated BM-MSC proliferation. Thus, LIGHT and LT[beta]R interaction increases the survival and proliferation of human BM-MSCs, and therefore, LIGHT might play an important role in stem cell therapy.
Audience Academic
Author Gwon, Gi-Dong
Noh, Eui-Kyu
Choi, Yunsuk
Baek, Jin Ho
Kim, Jeong Yi
Min, Young Joo
Heo, Sook-Kyoung
Jo, Jae-Cheol
Kim, Hawk
Koh, SuJin
Author_xml – sequence: 1
  fullname: Jo, Jae-Cheol
– sequence: 1
  fullname: Kim, Jeong Yi
– sequence: 1
  fullname: Heo, Sook-Kyoung
– sequence: 1
  fullname: Noh, Eui-Kyu
– sequence: 1
  fullname: Choi, Yunsuk
– sequence: 1
  fullname: Gwon, Gi-Dong
– sequence: 1
  fullname: Min, Young Joo
– sequence: 1
  fullname: Baek, Jin Ho
– sequence: 1
  fullname: Koh, SuJin
– sequence: 1
  fullname: Kim, Hawk
BookMark eNrjYmDJy89LZWLgNLQ0NtI1MzIwZkFiczBwFRdnGRiYGluYmXEysPp4unuE8DCwpiXmFKfyQmluBjU31xBnD930xJzU-IzUxJySjOL8nNKSzPy84nhHE3NDC1MLCwtjY6IVAgBRmCes
ContentType Journal Article
Copyright COPYRIGHT 2016 Public Library of Science
Copyright_xml – notice: COPYRIGHT 2016 Public Library of Science
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1932-6203
ExternalDocumentID A471858883
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BBORY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESTFP
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
P2P
P62
PATMY
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
ID FETCH-gale_healthsolutions_A4718588833
IEDL.DBID M48
ISSN 1932-6203
IngestDate Tue Aug 20 22:14:38 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel DirectLink
MergedId FETCHMERGED-gale_healthsolutions_A4718588833
ParticipantIDs gale_healthsolutions_A471858883
PublicationCentury 2000
PublicationDate 20161111
PublicationDateYYYYMMDD 2016-11-11
PublicationDate_xml – month: 11
  year: 2016
  text: 20161111
  day: 11
PublicationDecade 2010
PublicationTitle PloS one
PublicationYear 2016
Publisher Public Library of Science
Publisher_xml – name: Public Library of Science
SSID ssj0053866
Score 4.48247
Snippet LIGHT (HVEM-L, TNFSF14, or CD258), an entity homologous to lymphotoxins, with inducible nature and the ability to compete with herpes simplex virus...
SourceID gale
SourceType Aggregation Database
StartPage e0166589
SubjectTerms B cells
Dendritic cells
Enzyme-linked immunosorbent assay
Platelet-derived growth factor
Stem cell transplantation
Stem cells
T cells
Transforming growth factors
Tumor necrosis factor
Title LIGHT
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUuxSLI0A-3MNTJP1jVJtDDTtUw2MdVNTEsG1i6GacZmqaDNyb5-Zh6hJl4RphFMDLDZc2gAFmPt2oHukwotytGrKKy0h-RWYONDF2iRsRosKxuqQZ1rqAbJkKnAJg2wkgXv8DMyBmUBXxP4NAMws4MnM-HmQMtlpBrGTZCBH9o0VHCExKUQA1NqnjCDEDTzFStoQE-I1hRhYPXxdPcIEWVQc3MNcfbQBRkWD9nQCE9J8Y6g-sDUAnTLrxgDC7CTnyrBoABsGJimWaQapaUlJwHzVFKSkZlRqpl5kqlZmnmKeWKSJIM8AcOkCKqQZuACVvdmoJ10hoYyDCwlRaWpssAqtSRJDhwsILLOFQDhaXsW
link.rule.ids 315,786,790,2236
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LIGHT&rft.jtitle=PloS+one&rft.au=Jo%2C+Jae-Cheol&rft.au=Kim%2C+Jeong+Yi&rft.au=Heo%2C+Sook-Kyoung&rft.au=Noh%2C+Eui-Kyu&rft.date=2016-11-11&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=11&rft.issue=11&rft.spage=e0166589&rft.externalDBID=n%2Fa&rft.externalDocID=A471858883
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon